A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
Conditions
- Refractory Acute Myeloid Leukemia
- Relapsed Acute Myeloid Leukemia
- Acute Myeloid Leukemia
- Acute Myeloid Leukemia, in Relapse
- Acute Myeloid Leukemia Refractory
Interventions
- BIOLOGICAL: CD371-specific/YSNVz/I-18 CAR T cells
Sponsor
Memorial Sloan Kettering Cancer Center